Baztop 2 Mg Injection

Product Description

It is not recommended to take Baztop 2mg Injection if you are allergic to active compounds or any other ingredients of this medicine. It is not advised to take this medicine if you have a compromised immune system. If you have an active infection, let your doctor know before beginning any treatment.  It is not recommended to use Baztop 2mg Injection in children and adolescents. It is not recommended to use this medication in patients with hepatitis. 

Inform your doctor if you have gastrointestinal disorders, hepatic disorders, thrombocytopenia (low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), neuropathy (nerve malfunction), cardiac disorders, severe lung problems, pulmonary disorders and posterior reversible encephalopathy syndrome disorders before beginning the treatment with this medication. You are advised to monitor blood counts and hepatic enzymes throughout the treatment period.

The use of Baztop 2mg Injection during pregnancy and breastfeeding is not recommended and will be determined by the doctor only if absolutely necessary, as it may cause harm to the developing foetus. It is recommended to use effective contraceptive methods during the therapy and 3 months after completion. Inform your doctor if you are pregnant or planning to get pregnant to know about effective contraceptive methods.  It is necessary to inform your physician about all the medicines, over-the-counter drugs, vitamins and herbal supplements you are taking before the start of therapy.

How Baztop 2 mg Injection Works

Baztop 2 mg Injection contains Bortezomib, a proteasome inhibitor, which disrupts the growth and spread of cancer cells. It is specifically recommended for adults diagnosed with multiple myeloma or mantle cell lymphoma. The medicine is prepared and administered by medical professionals in a controlled clinical environment to ensure both efficacy and safety.


Proper Administration and Handling

Baztop 2 mg must be reconstituted with sterile normal saline before intravenous or subcutaneous injection. It is strictly meant for hospital or clinical use and is not for self-administration. Only qualified healthcare providers should handle and administer this medicine to avoid risk and ensure accurate dosing.


Safe Storage and Quality Assurance

To maintain its effectiveness, Baztop 2 mg Injection should be stored below 25C and protected from light. Each vial is intended for single use and should be kept out of children's reach. Carefully observe shelf life and storage guidelines, as recommended by the manufacturer.